In the article, The U.S. Is Standing in the Way of Cheaper Drugs for the Poor, the author Jason Cone and Raymond Offenheiser, state to the reader that being able to afford lifesaving drugs should not be based on where you live or how much you make due to the ever-inflating price of pharmaceutical drugs. Cone and Offenheiser, go on to say that even though many of the world leaders recognize the problem of high drug cost, due to the pharmaceutical company’s monopoly, the U.S. is going as far as to use “scare tactics” (Cone, Offenheiser, 2016) to undermine those, such as a panel of experts, who are trying to solve the problem. The authors also suggest to the reader that there are other ways to innovate the creation of drugs, for instance, through grants and prizes, that do not rely on the overpriced drugs created and provided by pharmaceutical companies. Lastly, the authors, …show more content…
For instance, an example of facts the authors use is when they tell the reader that EpiPen raised their price on treatment by 500 percent and that pharmaceutical companies do not produce lifesaving medicine’s that are non-profitable (Crone, Offenheiser, 2016). Logic is used when saying that for change to occur in the United States the “president must stop defending industry profits and work to reform how we pay for medical research to ensure that all patients’ needs are addressed” (Crone, Offenheiser, 2016). Expert opinion was used when the author’s informed the reader that Ban Ki-moon, the secretary-general of the United Nations, industry, government, academic and civil society experts, including Oxfam International’s executive director, recommended ways to reduce drug prices and develop new drugs and research (Crone, Offenheiser, 2016). The authors then showed how the Obama administration (U.S.) tried to devalue the panels recommendation’s by calling their work “deeply flawed” (Crone, Offenheiser,